MUC1 and Nuclear β-Catenin Are Coexpressed at the Invasion Front of Colorectal Carcinomas and Are Both Correlated with Tumor Prognosis
- 15 April 2004
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 10 (8) , 2790-2796
Abstract
Purpose: Overexpression of MUC1 and cytosolic interaction of the mucin with β-catenin are claimed to be involved in colorectal carcinogenesis. In vitro data published recently suggest that MUC1 overexpression results in an increase of steady state levels of nuclear β-catenin. We tried to elucidate the coexpression of both molecules in colorectal cancer to demonstrate possible correlations with clinical, pathological, and prognostic data. Experimental Design: An immunohistochemical double staining study was performed to characterize the expression and subcellular distribution of MUC1 and β-catenin in a series of 205 patients with colorectal carcinoma. The results were correlated with clinicopathological variables as well as overall survival. Results: MUC1 was strongly expressed in the tumor center and at the invasion front in ∼50% of the cases. Similar results were obtained with regard to nuclear accumulation of β-catenin at the invasive tumor parts. MUC1 protein expression in the tumor center correlated significantly with a low grade of differentiation, and nuclear β-catenin in the tumor periphery was more frequent in carcinomas of the left colon and rectum. Overexpression of MUC1 and β-catenin, as well as their nuclear coexpression at the invasion front correlated with a worse overall survival in an univariate analysis. However, only pathological tumor-node-metastasis staging and MUC1 at the invasion front revealed as independent prognostic factors. Conclusions: These results suggest that MUC1 and β-catenin are coexpressed at the invasion front of colorectal carcinomas and that this feature is associated with an accelerated course of disease and worse prognosis.Keywords
This publication has 29 references indexed in Scilit:
- Nuclear Association of the Cytoplasmic Tail of MUC1 and β-CateninJournal of Biological Chemistry, 2003
- A survival–stratification model of human colorectal carcinomas with β‐catenin and p27kip1Cancer, 2002
- Comparative evaluation of the prognostic value of MUC1, MUC2, sialyl‐Lewisa and sialyl‐Lewisx antigens in colorectal adenocarcinomaHistopathology, 2002
- Mechanisms of oncogenesis in colon versus rectal cancerThe Journal of Pathology, 2001
- MUC-1 expression as a predictor of the curative endoscopic treatment of submucosally invasive colorectal carcinomaDiseases of the Colon & Rectum, 1998
- Interaction of the DF3/MUC1 Breast Carcinoma-associated Antigen and β-Catenin in Cell AdhesionJournal of Biological Chemistry, 1997
- Functional interaction of β-catenin with the transcription factor LEF-1Nature, 1996
- Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components.Journal of Cell Biology, 1995
- The mucin epiglycanin on TA3/Ha carcinoma cells prevents alpha 6 beta 4-mediated adhesion to laminin and kalinin and E-cadherin-mediated cell-cell interaction.Journal of Cell Biology, 1994
- Tyrosine phosphorylation of the MUC1 breast cancer membrane proteins Cytokine receptor‐like moleculesFEBS Letters, 1994